These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21306761)

  • 21. Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacy.
    Jakobsen H; Hannesdottir S; Bjarnarson SP; Schulz D; Trannoy E; Siegrist CA; Jonsdottir I
    Eur J Immunol; 2006 Feb; 36(2):287-95. PubMed ID: 16385627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elderly subjects do not show impaired pneumococcal capsular polysaccharide serotype-specific antibody responses as assessed by a multiplexed bead assay.
    Borgers H; Jeurissen A; Flamaing J; Peetermans WE; Moens L; Verhaegen J; Bossuyt X
    Clin Immunol; 2010 Jun; 135(3):501-2. PubMed ID: 20207588
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE).
    Alexander J; del Guercio MF; Frame B; Maewal A; Sette A; Nahm MH; Newman MJ
    Vaccine; 2004 Jun; 22(19):2362-7. PubMed ID: 15193395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of antibodies to pneumococcal C polysaccharide in otitis media.
    Henrichsen J; Sørensen CH
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S26-7. PubMed ID: 2927979
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of the lymphatic pump on the immune response: I. Preliminary studies on the antibody response to pneumococcal polysaccharide assayed by bacterial agglutination and passive hemagglutination.
    Measel JW
    J Am Osteopath Assoc; 1982 Sep; 82(1):28-31. PubMed ID: 6897398
    [No Abstract]   [Full Text] [Related]  

  • 26. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
    Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
    Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of pneumococcal infection in a patient with normal immunoglobulin levels but impaired polysaccharide antibody production.
    Cohn JA; Skorpinski E; Cohn JR
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):603-5. PubMed ID: 17165266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.
    Saeland E; Jakobsen H; Ingolfsdottir G; Sigurdardottir ST; Jonsdottir I
    J Infect Dis; 2001 Jan; 183(2):253-260. PubMed ID: 11110649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interpretation of pneumococcal vaccine response.
    Scranton SE; Waibel KH
    Ann Allergy Asthma Immunol; 2007 May; 98(5):499-500. PubMed ID: 17521039
    [No Abstract]   [Full Text] [Related]  

  • 31. Response of transplant patient to pneumococcal vaccine.
    Arnold WC; Steele RW; Rastogi SP; Flanigan WJ
    Proc Clin Dial Transplant Forum; 1980; 10():57-61. PubMed ID: 7050994
    [No Abstract]   [Full Text] [Related]  

  • 32. Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children.
    Henckaerts I; Durant N; De Grave D; Schuerman L; Poolman J
    Vaccine; 2007 Mar; 25(13):2518-27. PubMed ID: 17034907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural maternal and cord serum antibodies to pneumococcal serotypes 6A, 14, 19F and 23F polysaccharides.
    Anderson P; Porcelli S; Pichichero M
    Pediatr Infect Dis J; 1992 Aug; 11(8):677-9. PubMed ID: 1523083
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunological paralysis to pneumococcal polysaccharide in man.
    Pichichero ME
    Lancet; 1985 Aug; 2(8453):468-71. PubMed ID: 2863493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease?
    Lipsitch M; Whitney CG; Zell E; Kaijalainen T; Dagan R; Malley R
    PLoS Med; 2005 Jan; 2(1):e15. PubMed ID: 15696204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Critical View of Specific Antibody Deficiencies.
    Sorensen RU
    Front Immunol; 2019; 10():986. PubMed ID: 31118939
    [No Abstract]   [Full Text] [Related]  

  • 38. [The characteristics of the humoral immune response to Streptococcus pneumoniae in children: The determination of antibodies in the blood serum, pleural fluid and saliva].
    Ulanova MA; Padiukov LN; Tatochenko VK; Kulak IuV; Katosova LK; Pugacheva NL; Aseeva VG
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Feb; (2):55-62. PubMed ID: 2343684
    [No Abstract]   [Full Text] [Related]  

  • 39. Different Immunological Pathways Underlie the Immune Response to Pneumococcal Polysaccharides.
    Moens L; Picard C; Shahrooei M; Wuyts G; Liston A; Fischer A; Bossuyt X
    J Clin Immunol; 2017 Apr; 37(3):277-278. PubMed ID: 28303442
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetic control of the immunologic response to pneumococcal capsular polysaccharides.
    Musher DM; Watson DA; Baughn RE
    Vaccine; 2000 Nov; 19(6):623-7. PubMed ID: 11090713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.